Last reviewed · How we verify
Prolonged antibiotic treatment — Competitive Intelligence Brief
marketed
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Prolonged antibiotic treatment (Prolonged antibiotic treatment) — Sheba Medical Center. Prolonged antibiotic treatment extends the duration of antimicrobial therapy to eliminate bacterial infections and reduce recurrence.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prolonged antibiotic treatment TARGET | Prolonged antibiotic treatment | Sheba Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prolonged antibiotic treatment CI watch — RSS
- Prolonged antibiotic treatment CI watch — Atom
- Prolonged antibiotic treatment CI watch — JSON
- Prolonged antibiotic treatment alone — RSS
Cite this brief
Drug Landscape (2026). Prolonged antibiotic treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/prolonged-antibiotic-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab